Skip to main content
. 2019 Apr 3;90(7):774–782. doi: 10.1136/jnnp-2018-319448

Table 2.

Intention-to-treat analysis of falling outcomes: 0–6 and 6–12 months

Period PDSAFE Control PDSAFE/Control*
OR (95% CI)
P value*
n (%)
Repeat falling restricted to ≥50% diaries Baseline 127/231 (55) 92/230 (40)
Baseline† 112/203 (55) 80/211 (38)
0–6 months 125/203 (62) 116/211 (55) 1.21 (0.74 to 1.98) 0.447
Baseline† 55/114 (48) 47/132 (36)
6–12 months 57/114 (50) 71/132 (54) 0.86 (0.45 to 1.65) 0.657
Falls/person/6 months‡ FRR (95% CI)
Fall rates Baseline 4.5 3.3
0–6 months 3.4 2.7 0.98 (0.80 to 1.19) 0.824
6–12 months 2.7 2.8 0.83 (0.62 to 1.11) 0.200
Near falls/person/6 months‡ NFRR (95% CI)
Near fall rates Baseline 8.0 8.1
0–6 months 4.7 5.6 0.67 (0.53 to 0.86) 0.001
6–12 months 3.9 3.7 1.01 (0.67 to 1.52) 0.968

*Controlled for site, age, gender, repeat falling or not in the year prior to screening, log number of falls in the year prior to screening, log rate of falling in the prerandomisation falls collection period and Hoehn and Yahr (NFRR additionally controlled for log rate of near falling in the prerandomisation falls collection period).

†Baseline repeat falling restricted to participants including in the 0–6 and 6–12 month analyses.

‡Geometric mean of individual fall rates with 0.5 added to all numerators.

FRR, fall rate ratio; NFRR, near fall rate ratio.